-transparent.png){kind=logo}
N-Nitroso-2-methoxy-2,6-dimethylmorpholine (MeNDMM) was derived from the cyclic form of N-nitroso-(2-hydroxypropyl)(2-oxopropyl)amine (HPOP), a proposed proximate pancreatic carcinogen for the hamster. MeNDMM was metabolized in vivo by noninbred Syrian golden hamsters to HPOP, which was excreted in urine. In vitro metabolism produced HPOP by cytochrome P450-mediated oxidative demethylation. MeNDMM and HPOP were similarly mutagenic in the Ames Salmonella typhimurium assay, in which hamster liver preparations were used for metabolic activation. MeNDMM, due to its metabolism to HPOP, is probably also a pancreatic carcinogen in the hamster.
Related Publications
R Gingell, and
G Brunk, and
D Nagel, and
L Wallcave, and
B Walker, and
P Pour
August 1981,
Cancer letters,
R Gingell, and
G Brunk, and
D Nagel, and
L Wallcave, and
B Walker, and
P Pour
February 1978,
Journal of the National Cancer Institute,
R Gingell, and
G Brunk, and
D Nagel, and
L Wallcave, and
B Walker, and
P Pour
January 1978,
Journal of the National Cancer Institute,
R Gingell, and
G Brunk, and
D Nagel, and
L Wallcave, and
B Walker, and
P Pour
May 1980,
Veterinary pathology,
R Gingell, and
G Brunk, and
D Nagel, and
L Wallcave, and
B Walker, and
P Pour
July 1984,
Chemico-biological interactions,
R Gingell, and
G Brunk, and
D Nagel, and
L Wallcave, and
B Walker, and
P Pour
July 1978,
Xenobiotica; the fate of foreign compounds in biological systems,
R Gingell, and
G Brunk, and
D Nagel, and
L Wallcave, and
B Walker, and
P Pour
March 1984,
Journal of the National Cancer Institute,
R Gingell, and
G Brunk, and
D Nagel, and
L Wallcave, and
B Walker, and
P Pour
February 1985,
Cancer research,
R Gingell, and
G Brunk, and
D Nagel, and
L Wallcave, and
B Walker, and
P Pour
January 1981,
Carcinogenesis,
R Gingell, and
G Brunk, and
D Nagel, and
L Wallcave, and
B Walker, and
P Pour
December 1982,
Cancer research,
